HighMark Wealth Management LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 58 filers reported holding TCR2 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HighMark Wealth Management LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,260
+50.2%
8400.0%0.00%0.0%
Q4 2022$839
-58.0%
8400.0%0.00%
-50.0%
Q3 2022$2,0000.0%8400.0%0.00%0.0%
Q2 2022$2,0000.0%8400.0%0.00%
+100.0%
Q1 2022$2,000
-50.0%
8400.0%0.00%
-66.7%
Q4 2021$4,000
-63.6%
840
-37.1%
0.00%
-62.5%
Q3 2021$11,000
-35.3%
1,335
+28.4%
0.01%
-33.3%
Q2 2021$17,000
-29.2%
1,040
-5.9%
0.01%
-36.8%
Q1 2021$24,0001,1050.02%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders